{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:06:10Z","timestamp":1779062770133,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"crossref","award":["2022R1F1A1067609"],"award-info":[{"award-number":["2022R1F1A1067609"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies on the association between coronavirus disease 2019 (COVID-19) and invasive pulmonary aspergillosis (IPA) were limited by their single-center nature and small patient population. Whether aspergillosis risk is related to COVID-19 or other factors remains unclear. This study aimed to determine whether COVID-19 among intensive care unit (ICU) patients is associated with an increased incidence of IPA compared with that among individuals with influenza or preexisting host factors (control).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a nationwide study performed using the Korean National Health Insurance Service database. A cohort of 28,089 patients with COVID-19 (2020\u20132022), 9993 individuals with influenza (2015\u20132019), and 11,807 control patients (2015\u20132019) were analyzed. Odds ratios (ORs) and 95% confidence intervals (CIs) of outcomes were calculated between the propensity score-matched groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, patients with COVID-19 were paired with 9649 patients with influenza (mean [SD] age, 72.7 [15.1] years vs. 72.7 [14.5] years; men, 53.3% vs. 52.2%) and 5709 control patients (mean [SD] age, 71.8 [12.0] years vs. 72.2 [11.1] years; men, 70.0% vs. 72.2%). The COVID-19 group was not associated with an increased risk of IPA compared to the observations in the influenza (OR, 1.20; 95% CI 0.97\u20131.48) or the control (OR, 1.06; 95% CI 0.89\u20131.26) group. Consistent findings were observed for patients receiving high-flow nasal cannula or mechanical ventilation. The risk factors for IPA included male sex, chronic pulmonary disease, chronic liver disease, admission to higher-volume hospitals, renal replacement therapy, and length of hospital stay; COVID-19 was not implicated (COVID-19 vs. influenza; adjusted OR, 1.22; 95% CI 0.97\u20131.54 and COVID-19 vs. control; adjusted OR, 1.17; 95% CI 0.97\u20131.42). In the COVID-19 group, corticosteroid use for \u2265\u20097 days was associated with an increased risk of IPA, regardless of the dosage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ICU patients with COVID-19 were not at an increased risk of IPA compared to those with influenza or preexisting host factors. COVID-19 may not predispose to IPA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13250-5","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:36:21Z","timestamp":1775475381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive pulmonary aspergillosis among ICU patients with COVID-19, influenza, and preexisting host factors: a nationwide cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Nakyung","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Seong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"13250_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1183\/09031936.00186214","volume":"45","author":"S Herold","year":"2015","unstructured":"Herold S, Becker C, Ridge KM, Budinger GR. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45:1463\u201378.","journal-title":"Eur Respir J"},{"key":"13250_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1183\/13993003.01282-2015","volume":"47","author":"KR Short","year":"2016","unstructured":"Short KR, Kasper J, van der Aa S, Andeweg AC, Zaaraoui-Boutahar F, Goeijenbier M, et al. Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. Eur Respir J. 2016;47:954\u201366.","journal-title":"Eur Respir J"},{"key":"13250_CR3","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","volume":"30","author":"JP Gangneux","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020;30:100971.","journal-title":"J Mycol Med"},{"key":"13250_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762\u20138.","journal-title":"Clin Infect Dis"},{"key":"13250_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jinf.2019.04.002","volume":"78","author":"M Stanzani","year":"2019","unstructured":"Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE. Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. J Infect. 2019;78:484\u201390.","journal-title":"J Infect"},{"key":"13250_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","volume":"196","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J, et al. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2017;196:524\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"13250_CR7","first-page":"1631","volume":"224","author":"F Lamoth","year":"2021","unstructured":"Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DP. Navigating the uncertainties of COVID-19-associated aspergillosis: a comparison with influenza-associated aspergillosis. J Infect Dis. 2021;224:1631\u201340.","journal-title":"J Infect Dis"},{"key":"13250_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","volume":"12","author":"F Gioia","year":"2024","unstructured":"Gioia F, Walti LN, Orchanian-Cheff A, Husain S. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Lancet Respir Med. 2024;12:207\u201316.","journal-title":"Lancet Respir Med"},{"key":"13250_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71:1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"13250_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERYC Group","year":"2021","unstructured":"Group RECOVERYC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693\u2013704.","journal-title":"N Engl J Med"},{"key":"13250_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u20138.","journal-title":"BMJ"},{"key":"13250_CR12","unstructured":"National Health Insurance Service. Population coverage. 2024. https:\/\/www.nhis.or.kr\/english\/wbheaa02400m01.do. Accessed 11 Mar 2025."},{"key":"13250_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"13250_CR14","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1097\/CCM.0000000000005015","volume":"49","author":"HW Cho","year":"2021","unstructured":"Cho HW, Song IA, Oh TK. Quality of life and long-term mortality among survivors of extracorporeal membrane oxygenation: a nationwide cohort study in South Korea. Crit Care Med. 2021;49:e771\u201380.","journal-title":"Crit Care Med"},{"key":"13250_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","volume":"63","author":"AW Meikle","year":"1977","unstructured":"Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63:200\u20137.","journal-title":"Am J Med"},{"key":"13250_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Dubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355.","journal-title":"Biometrika"},{"key":"13250_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa0801441","volume":"358","author":"KB Seung","year":"2008","unstructured":"Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781\u201392.","journal-title":"N Engl J Med"},{"key":"13250_CR18","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delliere S, Fodil S, Bretagne S, Megarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:e48\u20139.","journal-title":"Lancet Respir Med"},{"key":"13250_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","volume":"202","author":"ALE van Arkel","year":"2020","unstructured":"van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202:132\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"13250_CR20","doi-asserted-by":"publisher","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","volume":"73","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis. 2021;73:e3606\u201314.","journal-title":"Clin Infect Dis"},{"key":"13250_CR21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani JL. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect. 2020;26:1706\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"13250_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin JM, et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med. 2021;203:307\u201317.","journal-title":"Am J Respir Crit Care Med"},{"key":"13250_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","volume":"28","author":"RM Kariyawasam","year":"2022","unstructured":"Kariyawasam RM, Dingle TC, Kula BE, Vandermeer B, Sligl WI, Schwartz IS. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:920\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"13250_CR24","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Bruggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524\u201335.","journal-title":"Intensive Care Med"},{"key":"13250_CR25","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149\u201362.","journal-title":"Lancet Infect Dis"},{"key":"13250_CR26","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.3346\/jkms.2022.37.e134","volume":"37","author":"SH Kim","year":"2022","unstructured":"Kim SH, Hong JY, Bae S, Lee H, Wi YM, Ko JH, et al. Risk factors for coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis in critically ill patients: a nationwide, multicenter, retrospective cohort study. J Korean Med Sci. 2022;37:e134.","journal-title":"J Korean Med Sci"},{"key":"13250_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garcia","year":"2021","unstructured":"Salmanton-Garcia J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, et al. COVID-19-associated pulmonary aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27:1077\u201386.","journal-title":"Emerg Infect Dis"},{"key":"13250_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/thorax-2023-220002","volume":"79","author":"W Hurt","year":"2023","unstructured":"Hurt W, Youngs J, Ball J, Edgeworth J, Hopkins P, Jenkins DR, et al. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study. Thorax. 2023;79:75\u201382.","journal-title":"Thorax"},{"key":"13250_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","volume":"47","author":"PE Verweij","year":"2021","unstructured":"Verweij PE, Bruggemann RJM, Azoulay E, Bassetti M, Blot S, Buil JB, et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021;47:819\u201334.","journal-title":"Intensive Care Med"},{"key":"13250_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/cid\/ciad546","volume":"78","author":"S Feys","year":"2024","unstructured":"Feys S, Lagrou K, Lauwers HM, Haenen K, Jacobs C, Brusselmans M, et al. High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation. Clin Infect Dis. 2024;78:361\u201370.","journal-title":"Clin Infect Dis"},{"key":"13250_CR31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/ajt.16935","volume":"22","author":"P Phoompoung","year":"2022","unstructured":"Phoompoung P, Herrera S, Perez Cortes Villalobos A, Foroutan F, Orchanian-Cheff A, Husain S. Risk factors of invasive fungal infections in liver transplant recipients: A systematic review and meta-analysis. Am J Transpl. 2022;22:1213\u201329.","journal-title":"Am J Transpl"},{"key":"13250_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","volume":"31","author":"L Vanderbeke","year":"2018","unstructured":"Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2018;31:471\u201380.","journal-title":"Curr Opin Infect Dis"},{"key":"13250_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005;11:411\u201323.","journal-title":"Hum Reprod Update"},{"key":"13250_CR34","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.1300132","volume":"191","author":"I Kyrmizi","year":"2013","unstructured":"Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, et al. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1\/Syk kinase signaling. J Immunol. 2013;191:1287\u201399.","journal-title":"J Immunol"},{"key":"13250_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/myc.13637","volume":"66","author":"Z Hashim","year":"2023","unstructured":"Hashim Z, Nath A, Khan A, Gupta M, Kumar A, Chatterjee R, et al. Effect of glucocorticoids on the development of COVID-19-associated pulmonary aspergillosis: a meta-analysis of 21 studies and 5174 patients. Mycoses. 2023;66:941\u201352.","journal-title":"Mycoses"},{"key":"13250_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cid\/ciab223","volume":"74","author":"N Permpalung","year":"2022","unstructured":"Permpalung N, Chiang TP, Massie AB, Zhang SX, Avery RK, Nematollahi S, et al. Coronavirus disease 2019-associated pulmonary aspergillosis in mechanically ventilated patients. Clin Infect Dis. 2022;74:83\u201391.","journal-title":"Clin Infect Dis"},{"key":"13250_CR37","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942\u20139.","journal-title":"Nat Immunol"},{"key":"13250_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2022;28:580\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"13250_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","volume":"15","author":"NC Chesnaye","year":"2021","unstructured":"Chesnaye NC, Stel VS, Tripepi G, Dekker FW, Fu EL, Zoccali C, et al. An introduction to inverse probability of treatment weighting in observational research. Clin Kidney J. 2021;15:14\u201320.","journal-title":"Clin Kidney J"},{"key":"13250_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3904\/kjim.2022.069","volume":"37","author":"R Lee","year":"2022","unstructured":"Lee R, Cho SY, Lee DG, Ahn H, Choi H, Choi SM, et al. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: multicenter retrospective cohort study. Korean J Intern Med. 2022;37:851\u201363.","journal-title":"Korean J Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13250-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:17:56Z","timestamp":1779059876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13250-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13250"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13250-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol for the analysis of the de-identified patient data and the need for informed consent were exempted from review by the Institutional Review Board of Chung-Ang University (1041078-20230621-HR-168). Study procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"960"}}